Skip to content

Roopa Kanakatti Shankar

NPI 1659536696ActiveIndividual· Pediatrics, Pediatric Endocrinology· Washington, DC

Pediatrics, Pediatric Endocrinology in Washington, District of Columbia, licensed in DC, with an NPI issued in July 2008. Enrolled in Medicare as practitioner - pediatric medicine. Biomarin Pharmaceutical Inc. was the largest of 2 companies reporting payments in 2025, $9,605 in all, mostly consulting fees.

Overview

NPI1659536696
StatusActive
Entity typeIndividual
Sole proprietorYes
NPI issuedJul 18, 2008
Last updated in NPPESMay 15, 2020
Certified by providerMay 15, 2020

Specialties and licenses

TaxonomyCodeLicenseState
Pediatrics, Pediatric Endocrinology Primary2080P0205XMD046224DC

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Pediatric Medicine (DC)

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$9,605 · 8 payments from 2 companies
  • 2024$8,638 · 7 payments from 1 company

Top paying companies in 2025

CompanyAmountPayments
Biomarin Pharmaceutical Inc.$9,5817
Sequel Med Tech, LLC$23.641

What the 2025 payments were for

  • Consulting Fee$9,581 · 7 payments
  • Food and Beverage$23.64 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Pediatrics, Pediatric Endocrinology providers in Washington

All 29 Pediatrics, Pediatric Endocrinology providers in Washington · All Pediatrics, Pediatric Endocrinology providers in District of Columbia